Autism and Gene Therapy

The discussion reveals that autism prevalence is not unique to the U.S., with similar rates reported in countries like Korea and Denmark. Genetic mutations associated with autism appear consistent across diverse populations, suggesting a shared biological basis. Additionally, the potential of CRISPR technology in gene therapy is highlighted, raising questions about whether genetic fixes can occur in adulthood or must be implemented at the embryonic stage.